| Predictors for Poststroke Outcomes: Tel Aviv Brain Acute Stroke Cohort Acute Stroke Cohort (TABASCO) (NCT01926691) | Eli Sprecher, MD | 2008-04-01 |
| Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (NCT00663936) | FUJIFILM Toyama Chemical Co., Ltd. | 2008-04-01 |
| Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR) (NCT00688207) | GlaxoSmithKline | 2008-04-01 |
| Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects (NCT00689559) | AstraZeneca | 2008-03-01 |
| Effect of LY450139 on the Long Term Progression of Alzheimer's Disease (NCT00594568) | Eli Lilly and Company | 2008-03-01 |
| Memantine on Aggression and Agitation of Alzheimer's Disease (AD) (NCT00703430) | Peking University | 2008-03-01 |
| Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease (NCT00675090) | GlaxoSmithKline | 2008-02-21 |
| Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD) (NCT00637442) | University Hospital, Bonn | 2008-02-01 |
| Clinical Trial of Donepezil Between the Naive Group and the Switching Group (NCT01023425) | Samsung Medical Center | 2008-02-01 |
| Effects of Delivery Mode of Cognition Intervention in Early Alzheimer's Disease (NCT00611312) | University of Kansas | 2008-02-01 |
| A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease (NCT00607308) | Pfizer | 2008-02-01 |
| Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia (NCT00880347) | Exonhit | 2008-02-01 |
| Randomized Trial of a Nutritional Supplement in Alzheimer's Disease (NCT00678431) | US Department of Veterans Affairs | 2008-01-01 |
| Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System. (NCT00582127) | Neuronetrix, Inc. | 2008-01-01 |
| A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA) (NCT00622713) | Novartis | 2008-01-01 |
| Safety Study of Nicotinamide to Treat Alzheimer's Disease (NCT00580931) | University of California, Irvine | 2008-01-01 |
| Multi-modal Neuroimaging in Alzheimer's Disease (NCT01554202) | University Hospital, Caen | 2008-01-01 |
| Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease (NCT00602680) | Sanofi | 2008-01-01 |
| Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid (NCT00692705) | AstraZeneca | 2008-01-01 |
| Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease (NCT00566501) | Eisai Inc. | 2007-12-14 |
| Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) (NCT00575055) | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 2007-12-01 |
| Lutein and Alzheimer's Disease Study (NCT00596024) | Oregon Health and Science University | 2007-12-01 |
| A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease (NCT00566397) | Pfizer | 2007-12-01 |
| Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease (NCT00555204) | Abbott | 2007-11-01 |
| Memantine - Communication Study (NCT00624026) | Merz Pharmaceuticals GmbH | 2007-11-01 |
| Meditation or Education for Alzheimer Caregivers (NCT00558402) | Oregon Health and Science University | 2007-11-01 |
| Drug Interaction Study Between AZD3480 and Cytochrome P450 (NCT00692510) | AstraZeneca | 2007-11-01 |
| Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers (NCT00550420) | GlaxoSmithKline | 2007-10-01 |
| Effects of a Complex Cognitive Training in Mild Cognitive Impairment and Mild Alzheimer's Disease (NCT00544856) | Ludwig-Maximilians - University of Munich | 2007-10-01 |
| System-IGF-1 Pathway and Alzheimer's Disease (NCT00647478) | Assistance Publique - Hôpitaux de Paris | 2007-10-01 |
| Memory and Insulin in Early Alzheimer's Disease (NCT00581867) | Jeff Burns, MD | 2007-10-01 |
| Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy (NCT00499200) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-10-01 |
| Open Label Study of TRx0014 in Alzheimer's Disease (NCT00684944) | TauRx Therapeutics Ltd | 2007-09-13 |
| Home-Based Assessment for Alzheimer Disease Prevention (NCT00546767) | Alzheimer's Disease Cooperative Study (ADCS) | 2007-09-01 |
| Drug Interaction Study Between AZD3480 and Warfarin (NCT00689637) | AstraZeneca | 2007-09-01 |
| Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease (NCT00549601) | Novartis | 2007-09-01 |
| Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers (NCT00490568) | GlaxoSmithKline | 2007-08-08 |
| Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study (NCT00495820) | VA Office of Research and Development | 2007-08-01 |
| A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers. (NCT00551772) | GlaxoSmithKline | 2007-08-01 |
| Memory Disorders Registry (NCT00654563) | Cedars-Sinai Medical Center | 2007-08-01 |
| Online Caregiver Psychoeducation and Support for Alzheimer's (NCT00416078) | US Department of Veterans Affairs | 2007-08-01 |
| A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease (NCT00235716) | US Department of Veterans Affairs | 2007-08-01 |
| Neural Correlates In Mild Alzheimer's Disease (NCT00477659) | Eisai Inc. | 2007-07-23 |
| Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease (NCT00476008) | Florida Atlantic University | 2007-07-01 |
| Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid (NCT00742417) | Instituto Grifols, S.A. | 2007-07-01 |
| Home Safety Clinical Trial for Alzheimer's Disease (NCT00459355) | US Department of Veterans Affairs | 2007-07-01 |
| Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease (NCT00495417) | Affiris AG | 2007-07-01 |
| Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease (NCT00478205) | Eisai Inc. | 2007-06-01 |
| Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163 (NCT01454115) | Bristol-Myers Squibb | 2007-06-01 |
| Observational Study on Costs and Caregiver Burden in Alzheimer's Disease (NCT00698165) | AstraZeneca | 2007-06-01 |
| Safety Study of CTS21166 to Treat Alzheimer Disease (NCT00621010) | CoMentis | 2007-06-01 |
| Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers (NCT01035164) | Bayer | 2007-06-01 |
| Telephone Resources and Assistance for Caregivers (TRAC) (NCT00721383) | Rush University Medical Center | 2007-05-01 |
| A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease (NCT01928420) | Humanetics Corporation | 2007-04-01 |
| Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study (NCT03411291) | Cedars-Sinai Medical Center | 2007-04-01 |
| A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease (NCT00443417) | SK Chemicals Co., Ltd. | 2007-04-01 |
| Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone (NCT00392912) | Michael E. DeBakey VA Medical Center | 2007-04-01 |
| Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease (NCT00469456) | Forest Laboratories | 2007-04-01 |
| A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites. (NCT00468897) | GlaxoSmithKline | 2007-03-21 |
| A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease (NCT00459550) | GlaxoSmithKline | 2007-03-12 |
| A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease (NCT01734395) | Janssen Korea, Ltd., Korea | 2007-03-01 |
| Evaluating the Effects of Music Interventions on Hospitalised People With Dementia (NCT00448318) | National Ageing Research Institute, Australia | 2007-03-01 |
| Wisconsin Brain Donor Program (NCT00585572) | University of Wisconsin, Madison | 2007-03-01 |
| Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia (NCT01023867) | Samsung Medical Center | 2007-03-01 |
| A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease (NCT00455000) | Pfizer | 2007-03-01 |
| Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease (NCT00428090) | GlaxoSmithKline | 2007-02-27 |
| DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease (NCT00440050) | Alzheimer's Disease Cooperative Study (ADCS) | 2007-02-01 |
| Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid (NCT00439166) | Hamilton Health Sciences Corporation | 2007-02-01 |
| An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease (NCT00814801) | Janssen Pharmaceutical K.K. | 2007-02-01 |
| Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease (NCT00454870) | Memory Pharmaceuticals | 2007-02-01 |
| Observational Study Of Donepezil In Routine Clinical Practice (NCT00843115) | Pfizer | 2007-02-01 |
| Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease (NCT00423085) | Novartis Pharmaceuticals | 2007-01-01 |
| Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease (NCT00428389) | Novartis | 2007-01-01 |
| MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems (NCT00413621) | National Institute of Neurological Disorders and Stroke (NINDS) | 2006-12-14 |
| Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease (NCT00408525) | Vanderbilt University | 2006-12-01 |
| A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease. (NCT00531804) | Hoffmann-La Roche | 2006-12-01 |
| Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease (NCT00471211) | Prana Biotechnology Limited | 2006-12-01 |
| PET Imaging of Brain Amyloid Using [11C]MeS-IMPY (NCT00407576) | National Institute of Mental Health (NIMH) | 2006-12-01 |
| AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease (NCT00606476) | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 2006-12-01 |
| Memantine for Agitation and Aggression in Severe Alzheimer's Disease (NCT00401167) | Sunnybrook Health Sciences Centre | 2006-11-01 |
| Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers (NCT00403520) | Eisai Inc. | 2006-11-01 |
| MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED) (NCT00362024) | Merck Sharp & Dohme LLC | 2006-11-01 |
| MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011) (NCT00420420) | Merck Sharp & Dohme LLC | 2006-11-01 |
| Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept (NCT00384423) | Epix Pharmaceuticals, Inc. | 2006-10-01 |
| Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients (NCT00375557) | University of Cincinnati | 2006-10-01 |
| The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease (NCT01054976) | Janssen Korea, Ltd., Korea | 2006-10-01 |
| Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients (NCT00369603) | Duke University | 2006-10-01 |
| Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol (NCT00380276) | Myrexis Inc. | 2006-09-01 |
| Efficacy of Early Stage Alzheimer's Support Groups (NCT00391794) | University of Washington | 2006-09-01 |
| Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®) (NCT00523666) | Ludwig-Maximilians - University of Munich | 2006-09-01 |
| Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training (NCT00120874) | NYU Langone Health | 2006-08-01 |
| LifeZig Personalized Reminiscence Video With Slideshows and Music for Individuals With Alzheimer's and Dementia (NCT00759863) | Photozig, Inc. | 2006-08-01 |
| Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease (NCT00348140) | GlaxoSmithKline | 2006-07-12 |
| Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease (NCT00348309) | GlaxoSmithKline | 2006-07-06 |
| European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients (NCT00357357) | Hunter-Fleming Ltd | 2006-07-01 |
| Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease (NCT00381238) | GlaxoSmithKline | 2006-06-20 |
| Cerebral and Peripheral Perfusion Pilot Study (NCT00751907) | University of Wisconsin, Madison | 2006-06-01 |
| The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease (NCT00381381) | Eisai Korea Inc. | 2006-05-31 |
| Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease (NCT00314912) | Bellus Health Inc. - a GSK company | 2006-05-01 |
| SB-742457 And Donepezil In Alzheimer's Disease (NCT00348192) | GlaxoSmithKline | 2006-05-01 |